Paul Proost

28.4k total citations · 5 hit papers
387 papers, 22.3k citations indexed

About

Paul Proost is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Paul Proost has authored 387 papers receiving a total of 22.3k indexed citations (citations by other indexed papers that have themselves been cited), including 171 papers in Oncology, 162 papers in Immunology and 142 papers in Molecular Biology. Recurrent topics in Paul Proost's work include Chemokine receptors and signaling (145 papers), Cell Adhesion Molecules Research (70 papers) and Immune Response and Inflammation (61 papers). Paul Proost is often cited by papers focused on Chemokine receptors and signaling (145 papers), Cell Adhesion Molecules Research (70 papers) and Immune Response and Inflammation (61 papers). Paul Proost collaborates with scholars based in Belgium, United States and Italy. Paul Proost's co-authors include Jo Van Damme, Ghislain Opdenakker, Sofie Struyf, Mieke Gouwy, Anja Wuyts, Philippe E. Van den Steen, Anneleen Mortier, Jean‐Pierre Lenaerts, Rik Janssens and Mieke Metzemaekers and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Paul Proost

385 papers receiving 21.9k citations

Hit Papers

Neutrophil gelatinase B potentiates interleukin-8 tenfold... 2000 2026 2008 2017 2000 2002 2020 2023 2023 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-α and leaves RANTES and MCP-2 intact
    2000 564 citations Philippe E. Van den Steen, Paul Proost et al. Blood profile →
  2. HIV-1 Integrase Forms Stable Tetramers and Associates with LEDGF/p75 Protein in Human Cells
    2002 543 citations Paul Proost et al. profile →
  3. Neutrophil chemoattractant receptors in health and disease: double-edged swords
    2020 332 citations Mieke Metzemaekers, Mieke Gouwy et al. Cellular and Molecular Immunology profile →
  4. The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention
    2023 260 citations Seppe Cambier, Mieke Gouwy et al. Cellular and Molecular Immunology profile →
  5. Matrix metalloproteinases in arthritis: towards precision medicine
    2023 110 citations Bernard Grillet, Jo Van Damme et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Proost Belgium 84 8.0k 7.4k 7.2k 2.6k 2.4k 387 22.3k
Toshio Hirano Japan 85 10.8k 1.4× 10.2k 1.4× 8.7k 1.2× 2.7k 1.0× 1.2k 0.5× 220 29.3k
Jo Van Damme Belgium 108 16.7k 2.1× 12.7k 1.7× 13.7k 1.9× 4.4k 1.7× 4.2k 1.8× 547 41.8k
Jack A. Elias United States 88 9.7k 1.2× 8.5k 1.2× 2.7k 0.4× 1.7k 0.6× 2.1k 0.9× 300 27.9k
Ghislain Opdenakker Belgium 91 9.4k 1.2× 9.5k 1.3× 8.6k 1.2× 8.0k 3.1× 3.4k 1.4× 512 30.1k
Peter Angel Germany 75 5.1k 0.6× 17.7k 2.4× 5.9k 0.8× 6.1k 2.4× 1.7k 0.7× 186 29.1k
Dennis A. Carson United States 88 11.1k 1.4× 11.4k 1.6× 5.7k 0.8× 1.7k 0.7× 993 0.4× 467 29.3k
Naofumi Mukaida Japan 89 12.5k 1.6× 7.3k 1.0× 7.8k 1.1× 3.6k 1.4× 1.8k 0.7× 376 28.4k
David R. Greaves United Kingdom 67 7.1k 0.9× 7.1k 1.0× 3.5k 0.5× 1.2k 0.5× 1.0k 0.4× 183 16.9k
Wim B. van den Berg Netherlands 99 10.4k 1.3× 10.8k 1.5× 5.1k 0.7× 3.4k 1.3× 2.4k 1.0× 451 32.9k
Stuart H. Yuspa United States 83 2.4k 0.3× 13.6k 1.8× 4.5k 0.6× 3.1k 1.2× 1.2k 0.5× 328 23.4k

Countries citing papers authored by Paul Proost

Since Specialization
Citations

This map shows the geographic impact of Paul Proost's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Proost with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Proost more than expected).

Fields of papers citing papers by Paul Proost

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Proost. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Proost. The network helps show where Paul Proost may publish in the future.

Co-authorship network of co-authors of Paul Proost

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Proost. A scholar is included among the top collaborators of Paul Proost based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Proost. Paul Proost is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gouwy, Mieke, et al.. (2025). Neutrophils in BCR::ABL1 negative MPN: Contributors or bystanders of fibrosis?. Blood Reviews. 72. 101285–101285. 1 indexed citations
2.
Metzemaekers, Mieke, Bert Malengier‐Devlies, Mieke Gouwy, et al.. (2023). Fast and furious: The neutrophil and its armamentarium in health and disease. Medicinal Research Reviews. 43(5). 1537–1606. 16 indexed citations
3.
Berghmans, Nele, Sam Noppen, Erik Martens, et al.. (2022). A stabilized CXCL9(74–103)-derived peptide selectively inhibits proliferation, adhesion and metastasis of tumor cells that express high levels of heparan sulfate. International Journal of Biological Macromolecules. 222(Pt B). 2808–2822. 3 indexed citations
4.
Cambier, Seppe, Noëmie Pörtner, Sofie Struyf, et al.. (2021). Affinity and Specificity for Binding to Glycosaminoglycans Can Be Tuned by Adapting Peptide Length and Sequence. International Journal of Molecular Sciences. 23(1). 447–447. 11 indexed citations
5.
Metzemaekers, Mieke, Anneleen Mortier, Daiane Boff, et al.. (2021). Endogenous modification of the chemoattractant CXCL5 alters receptor usage and enhances its activity toward neutrophils and monocytes. Science Signaling. 14(673). 13 indexed citations
6.
Metzemaekers, Mieke, Mieke Gouwy, & Paul Proost. (2020). Neutrophil chemoattractant receptors in health and disease: double-edged swords. Cellular and Molecular Immunology. 17(5). 433–450. 332 indexed citations breakdown →
7.
Buck, Mieke De, Mieke Gouwy, Ji Ming Wang, et al.. (2015). The cytokine-serum amyloid A-chemokine network. Cytokine & Growth Factor Reviews. 30. 55–69. 112 indexed citations
8.
Piccard, Heléne, Jialiang Hu, Pierre Fiten, et al.. (2009). “Reverse degradomics”, monitoring of proteolytic trimming by multi‐CE and confocal detection of fluorescent substrates and reaction products. Electrophoresis. 30(13). 2366–2377. 11 indexed citations
9.
Proost, Paul, Tamara Loos, Anneleen Mortier, et al.. (2008). Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation. The Journal of Experimental Medicine. 205(9). 2085–2097. 149 indexed citations
10.
Struyf, Sofie, Marie D. Burdick, Elke Peeters, et al.. (2007). Platelet Factor-4 Variant Chemokine CXCL4L1 Inhibits Melanoma and Lung Carcinoma Growth and Metastasis by Preventing Angiogenesis. Cancer Research. 67(12). 5940–5948. 88 indexed citations
11.
Proost, Paul, Anneleen Mortier, Tamara Loos, et al.. (2007). Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration. Blood. 110(1). 37–44. 113 indexed citations
12.
Loos, Tamara, Sofie Struyf, Evemie Schutyser, et al.. (2006). TLR ligands and cytokines induce CXCR3 ligands in endothelial cells: enhanced CXCL9 in autoimmune arthritis. Laboratory Investigation. 86(9). 902–916. 101 indexed citations
13.
Struyf, Sofie, Marie D. Burdick, Paul Proost, Jo Van Damme, & Robert M. Strieter. (2004). Platelets Release CXCL4L1, a Nonallelic Variant of the Chemokine Platelet Factor-4/CXCL4 and Potent Inhibitor of Angiogenesis. Circulation Research. 95(9). 855–857. 126 indexed citations
14.
Abe, Karon, et al.. (2002). TNF alpha up-regulates the expression and function of amyloid beta receptor in murine microgial cells. The FASEB Journal. 16(5). 1 indexed citations
15.
Chen, Ying, Frank Vandenbussche, Pierre Rougé, et al.. (2002). A complex fruit‐specific type‐2 ribosome‐inactivating protein from elderberry (Sambucus nigra) is correctly processed and assembled in transgenic tobacco plants. European Journal of Biochemistry. 269(12). 2897–2906. 11 indexed citations
16.
Starckx, Sofie, Anja Wuyts, Els Van Coillie, et al.. (2002). Recombinant Mouse Granulocyte Chemotactic Protein-2: Production in Bacteria, Characterization, and Systemic Effects on Leukocytes. Journal of Interferon & Cytokine Research. 22(9). 965–974. 5 indexed citations
17.
Wuyts, Anja, Patricia Menten, Jean‐Pierre Lenaerts, et al.. (1999). NH2- and COOH-Terminal Truncations of Murine Granulocyte Chemotactic Protein-2 Augment the In Vitro and In Vivo Neutrophil Chemotactic Potency. The Journal of Immunology. 163(11). 6155–6163. 51 indexed citations
18.
Masure, Stefan, Liesbet Paemen, Paul Proost, Jo Van Damme, & Ghislain Opdenakker. (1995). Expression of a Human Mutant Monocyte Chemotactic Protein 3 in Pichia pastoris and Characterization as an MCP-3 Receptor Antagonist. Journal of Interferon & Cytokine Research. 15(11). 955–963. 23 indexed citations
19.
Forsythe, Paul, Susan Stafford, R. Bravo, et al.. (1994). Fibroblast-induced cytokine (fic) and monocyte chemoattractant peptide-2 (mcp-2), 2 new beta-chemokines, cause basophil histamine-release. Journal of Allergy and Clinical Immunology. 93(1). 215–215. 3 indexed citations
20.
Opdenakker, Ghislain, Stefan Masure, Paul Proost, Alfons Billiau, & Jo Van Damme. (1991). Natural human monocyte gelatinase and its inhibitor. FEBS Letters. 284(1). 73–78. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshio Hirano Breakdown of academic impact, for papers by Jo Van Damme Breakdown of academic impact, for papers by Jack A. Elias Breakdown of academic impact, for papers by Ghislain Opdenakker Breakdown of academic impact, for papers by Peter Angel Breakdown of academic impact, for papers by Dennis A. Carson Breakdown of academic impact, for papers by Naofumi Mukaida Breakdown of academic impact, for papers by David R. Greaves Breakdown of academic impact, for papers by Wim B. van den Berg Breakdown of academic impact, for papers by Stuart H. Yuspa
Rankless by CCL
2026